212 related articles for article (PubMed ID: 37217509)
21. NFkappaB modulators in a model of glucocorticoid resistant, childhood acute lymphoblastic leukemia.
Nicholson L; Hall AG; Redfern CP; Irving J
Leuk Res; 2010 Oct; 34(10):1366-73. PubMed ID: 20106524
[TBL] [Abstract][Full Text] [Related]
22. Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting.
Karvonen H; Perttilä R; Niininen W; Hautanen V; Barker H; Murumägi A; Heckman CA; Ungureanu D
Oncogene; 2019 Apr; 38(17):3288-3300. PubMed ID: 30631148
[TBL] [Abstract][Full Text] [Related]
23. Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance.
Han SS; Han S; Kamberos NL
Biochem Biophys Res Commun; 2014 Sep; 452(3):669-75. PubMed ID: 25193702
[TBL] [Abstract][Full Text] [Related]
24. Glucocorticoid receptor knock down reveals a similar apoptotic threshold but differing gene regulation patterns in T-cell and pre-B-cell acute lymphoblastic leukemia.
Schwartz JR; Sarvaiya PJ; Vedeckis WV
Mol Cell Endocrinol; 2010 May; 320(1-2):76-86. PubMed ID: 20170710
[TBL] [Abstract][Full Text] [Related]
25. Effect of tumor necrosis factor-alpha on the proliferation of leukemic cells from children with B-cell precursor-acute lymphoblastic leukemia (BCP-ALL): studies of primary leukemic cells and BCP-ALL cell lines.
Zhou MX; Findley HW; Ma LH; Zaki SR; Hill T; Hamid M; Hooper WC; Ragab AH
Blood; 1991 May; 77(9):2002-7. PubMed ID: 2018837
[TBL] [Abstract][Full Text] [Related]
26. Expression of 11beta-hydroxysteroid dehydrogenase 2 contributes to glucocorticoid resistance in lymphoblastic leukemia cells.
Sai S; Nakagawa Y; Yamaguchi R; Suzuki M; Sakaguchi K; Okada S; Seckl JR; Ohzeki T; Chapman KE
Leuk Res; 2011 Dec; 35(12):1644-8. PubMed ID: 21794917
[TBL] [Abstract][Full Text] [Related]
27. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor.
Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG
Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130
[TBL] [Abstract][Full Text] [Related]
28. Glucocorticoid resistance in two key models of acute lymphoblastic leukemia occurs at the level of the glucocorticoid receptor.
Schmidt S; Irving JA; Minto L; Matheson E; Nicholson L; Ploner A; Parson W; Kofler A; Amort M; Erdel M; Hall A; Kofler R
FASEB J; 2006 Dec; 20(14):2600-2. PubMed ID: 17077285
[TBL] [Abstract][Full Text] [Related]
29. Low-dose anisomycin sensitizes glucocorticoid-resistant T-acute lymphoblastic leukemia CEM-C1 cells to dexamethasone-induced apoptosis through activation of glucocorticoid receptor and p38-MAPK/JNK.
Liu Y; Ge J; Li Q; Guo X; Gu L; Ma ZG; Li XH; Zhu YP
Leuk Lymphoma; 2014 Sep; 55(9):2179-88. PubMed ID: 24597985
[TBL] [Abstract][Full Text] [Related]
30. Targeting mTOR/p70S6K/glycolysis signaling pathway restores glucocorticoid sensitivity to 4E-BP1 null Burkitt Lymphoma.
Gu L; Xie L; Zuo C; Ma Z; Zhang Y; Zhu Y; Gao J
BMC Cancer; 2015 Jul; 15():529. PubMed ID: 26189041
[TBL] [Abstract][Full Text] [Related]
31. Mutual antagonism between glucocorticoid and canonical Wnt signaling pathways in B-cell acute lymphoblastic leukemia.
Bergeron BP; Barnett KR; Bhattarai KR; Mobley RJ; Hansen BS; Brown A; Kodali K; High AA; Jeha S; Pui CH; Peng J; Pruett-Miller SM; Savic D
Blood Adv; 2023 Aug; 7(15):4107-4111. PubMed ID: 37289547
[No Abstract] [Full Text] [Related]
32. Role of microRNAs in glucocorticoid‑resistant B‑cell precursor acute lymphoblastic leukemia.
Sakurai N; Komada Y; Hanaki R; Morimoto M; Ito T; Nakato D; Hirayama M
Oncol Rep; 2019 Aug; 42(2):708-716. PubMed ID: 31233193
[TBL] [Abstract][Full Text] [Related]
33. Lack of association between deletion polymorphism of BIM gene and in vitro drug sensitivity in B-cell precursor acute lymphoblastic leukemia.
Huang M; Miyake K; Kagami K; Abe M; Shinohara T; Watanabe A; Somazu S; Oshiro H; Goi K; Goto H; Minegishi M; Iwamoto S; Kiyokawa N; Sugita K; Inukai T
Leuk Res; 2017 Sep; 60():24-30. PubMed ID: 28641145
[TBL] [Abstract][Full Text] [Related]
34. CBP Modulates Sensitivity to Dasatinib in Pre-BCR
Duque-Afonso J; Lin CH; Han K; Morgens DW; Jeng EE; Weng Z; Jeong J; Wong SHK; Zhu L; Wei MC; Chae HD; Schrappe M; Cario G; Duyster J; Xiao X; Sakamoto KM; Bassik MC; Cleary ML
Cancer Res; 2018 Nov; 78(22):6497-6508. PubMed ID: 30262461
[TBL] [Abstract][Full Text] [Related]
35. Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children.
Koga Y; Matsuzaki A; Suminoe A; Hattori H; Kanemitsu S; Hara T
Pediatr Blood Cancer; 2005 Aug; 45(2):121-7. PubMed ID: 15704223
[TBL] [Abstract][Full Text] [Related]
36. A novel method to establish glucocorticoid resistant acute lymphoblastic leukemia cell lines.
Gu L; Zhang G; Zhang Y
J Exp Clin Cancer Res; 2019 Jun; 38(1):269. PubMed ID: 31221196
[TBL] [Abstract][Full Text] [Related]
37. Glucocorticoid-induced glucocorticoid-receptor expression and promoter usage is not linked to glucocorticoid resistance in childhood ALL.
Tissing WJ; Meijerink JP; Brinkhof B; Broekhuis MJ; Menezes RX; den Boer ML; Pieters R
Blood; 2006 Aug; 108(3):1045-9. PubMed ID: 16574952
[TBL] [Abstract][Full Text] [Related]
38. Glucocorticoid-induced granzyme A expression can be used as a marker of glucocorticoid sensitivity for acute lymphoblastic leukemia therapy.
Myoumoto A; Nakatani K; Koshimizu TA; Matsubara H; Adachi S; Tsujimoto G
J Hum Genet; 2007; 52(4):328-333. PubMed ID: 17310274
[TBL] [Abstract][Full Text] [Related]
39. Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines.
Beesley AH; Weller RE; Senanayake S; Welch M; Kees UR
Leuk Res; 2009 Feb; 33(2):321-5. PubMed ID: 18789525
[TBL] [Abstract][Full Text] [Related]
40. PON2 blockade overcomes dexamethasone resistance in acute lymphoblastic leukemia.
Hui PY; Chen YH; Qin J; Jiang XH
Hematology; 2022 Dec; 27(1):32-42. PubMed ID: 34957927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
